Sobrevida de Pacientes Transplantados Cardíacos com Doença de Chagas Sob Diferentes Regimes de Imunossupressores Antiproliferativos

Furquim, Silas Ramos; Galbiati, Luana Campoli; Avila, Monica S.; Marcondes-Braga, Fabiana G.; Fukushima, Julia; Mangini, Sandrigo; Seguro, Luis Fernando Bernal da Costa; Campos, Iascara Wozniak de; Strabelli, Tania Mara Varejão; Barone, Fernanda; Paulo, Audrey Rose da Silveira Amancio de; Ohe, Luciana Akutsu; Galante, Mariana Cappelletti; Gaiotto, Fabio Antonio; Bacal, Fernando

doi:10.36660/abc.20230133

Arquivos Brasileiros De Cardiologia

2023

DOI: 10.36660/abc.20230133

|View full text |Cite

Sobrevida de Pacientes Transplantados Cardíacos com Doença de Chagas Sob Diferentes Regimes de Imunossupressores Antiproliferativos

Silas Ramos Furquim,

Luana Campoli Galbiati,

Monica S. Avila

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Chagas disease in immunocompromised patients

Clark,

Messenger,

Whitman

et al. 2024

Clin Microbiol Rev

View full text Add to dashboard Cite

SUMMARY As Chagas disease remains prevalent in the Americas, it is important that healthcare professionals and researchers are aware of the screening, diagnosis, monitoring, and treatment recommendations for the populations of patients they care for and study. Management of Trypanosoma cruzi infection in immunocompromised hosts is challenging, particularly because, regardless of antitrypanosomal treatment status, immunocompromised patients with Chagas disease are at risk for T. cruzi reactivation, which can be lethal. Evidence-based practices to prevent and manage T. cruzi reactivation vary depending on the type of immunocompromise. Here, we review available data describing Chagas disease epidemiology, testing, and management practices for various populations of immunocompromised individuals, including people with HIV and patients undergoing solid organ and hematopoietic stem cell transplantation.

show abstract

Chagas disease in immunocompromised patients

Clark,

Messenger,

Whitman

et al. 2024

Clin Microbiol Rev

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Sobrevida de Pacientes Transplantados Cardíacos com Doença de Chagas Sob Diferentes Regimes de Imunossupressores Antiproliferativos

Cited by 1 publication

References 14 publications

Chagas disease in immunocompromised patients

Chagas disease in immunocompromised patients

Contact Info

Product

Resources

About